Garmin Fenix 7 Beta 26.09 Update Shows Early ECG Testing Signals, But No Public Rollout Yet

Key takeaway

Garmin’s latest beta firmware 26.09 for the Fenix 7 series is focused on stability fixes, but early reports suggest ECG functionality may now be active in limited testing. There is still no official confirmation of a public ECG rollout.

What happened in the Garmin beta 26.09 update

Garmin has released beta firmware version 26.09 for multiple premium smartwatch models, including:
  • Fenix 7 series
  • Epix
  • Enduro 2
  • Quatix 7
  • MARQ Gen 2
The update is described as a routine stability release.
A photo of a person hands shows Garmin fenix 7 smart watch


Confirmed changes include:

  • Fixes for Garmin Connect text mismatches in Power Manager
  • Resolution of unexpected shutdowns during Garmin Coach sessions
  • Improvements to inReach widget navigation behavior

These changes indicate maintenance-level development rather than a major feature drop.

ECG functionality appears in limited beta testing

The most notable development is that ECG-related functionality appears to be enabled in controlled beta testing environments on select devices.

However:

  • Garmin has not issued a public statement confirming ECG rollout in this build
  • The feature is not widely available across all beta users
  • Availability may vary depending on region and device configuration

At this stage, this should be treated as early-stage testing behavior, not a confirmed release.

Why ECG matters in Garmin firmware updates

ECG (electrocardiogram) tracking is a regulated health feature used to detect irregular heart rhythms such as atrial fibrillation.

Unlike standard smartwatch features, ECG requires:

  • Medical-grade regulatory approval in each region
  • Strict sensor accuracy validation
  • Stable signal processing across firmware builds

Because of these requirements, manufacturers typically restrict ECG testing until later stages of firmware validation.

What this beta update likely indicates (analysis, not confirmation)

Based on previous Garmin firmware cycles, updates with similar structure often appear when:
  • Core system stability work is nearly complete
  • Feature development is slowing down
  • Sensitive health features enter controlled validation
However, Garmin has not confirmed that beta 26.09 represents a final-stage release candidate.

Important limitation: rollout is not only technical

Even if ECG becomes fully stable in firmware, availability depends on:
  • Regional medical device approvals
  • Country-specific certification rules
  • Garmin’s staged rollout strategy

This means ECG may not appear at the same time globally, even on identical devices.

Garmin vs Apple and Samsung approach

Garmin’s rollout strategy differs from competitors:

Garmin

Longer beta validation cycles

Gradual feature activation

Heavy focus on stability before public release

Apple and Samsung

  • Faster ECG integration into stable updates
  • Earlier public rollout of health features
  • More frequent incremental refinements

This explains why Garmin features often appear later but are typically more stable at launch.

What Fenix 7 users should expect next

Based on current firmware behavior, three outcomes are possible:

1. Stable release after final beta testing

A public 26.xx firmware may follow after final validation.

2. Gradual ECG rollout by region

ECG may appear first in select markets depending on approvals.

3. Extended beta phase

Garmin may continue testing without immediate public release.

No timeline has been confirmed by Garmin.

What users can do now

For Fenix 7 owners:

  • Keep firmware updated via Garmin Connect
  • Check health settings for ECG availability (if supported in your region)
  • Avoid assuming ECG activation until stable release notes confirm it
  • No immediate action is required.

Bottom line

The Garmin Fenix 7 beta 26.09 update is primarily a stability release. However, limited ECG testing activity suggests the feature may be approaching advanced validation stages.

Still, Garmin has not confirmed any public ECG rollout timeline, and availability will depend on regulatory approval and regional deployment decisions.

External references and further reading